Please provide your email address to receive an email when new articles are posted on . UnitedHealthcare will now cover Tandem Diabetes’ insulin pumps in network, a reversal of a previous policy ...

Tandem Diabetes Care has agreed to pay Roche Holding $36 million to settle a patent infringement claim. The two companies have granted each other licenses to patents on the insulin delivery systems in ...

RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin ...

Tandem Diabetes Care (Nasdaq:TNDM) recently filed an SEC Form 8-K announcing its entry into a patent litigation settlement ...

Diabetes technology company Tandem Diabetes Care (NASDAQ ... can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free.

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q4 CY2024, with sales up 35% year on year to $282.6 million. The company expects next quarter’s revenue to be around $221.5 ...

It’s been a roller coaster of a year for Tandem Diabetes Care. It kicked off the ... that wasn’t the case this year. August’s results were promising, he said, “but then, different from ...

Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery ...